nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—ADRB1—Levobunolol—glaucoma	0.0476	0.0622	CbGbCtD
Loxapine—ADRB1—Metipranolol—glaucoma	0.0476	0.0622	CbGbCtD
Loxapine—ADRA2C—Brimonidine—glaucoma	0.0419	0.0547	CbGbCtD
Loxapine—ADRA2C—Apraclonidine—glaucoma	0.0419	0.0547	CbGbCtD
Loxapine—ADRB1—Carteolol—glaucoma	0.0405	0.0529	CbGbCtD
Loxapine—ADRA2B—Brimonidine—glaucoma	0.0397	0.0519	CbGbCtD
Loxapine—ADRA2B—Apraclonidine—glaucoma	0.0397	0.0519	CbGbCtD
Loxapine—ADRA2C—Dipivefrin—glaucoma	0.0335	0.0437	CbGbCtD
Loxapine—ADRA2B—Dipivefrin—glaucoma	0.0318	0.0415	CbGbCtD
Loxapine—CHRM3—Carbachol—glaucoma	0.0288	0.0376	CbGbCtD
Loxapine—ADRA2A—Brimonidine—glaucoma	0.0276	0.0361	CbGbCtD
Loxapine—ADRA2A—Apraclonidine—glaucoma	0.0276	0.0361	CbGbCtD
Loxapine—ADRB1—Betaxolol—glaucoma	0.0274	0.0357	CbGbCtD
Loxapine—CHRM3—Pilocarpine—glaucoma	0.0267	0.0349	CbGbCtD
Loxapine—ADRA1A—Apraclonidine—glaucoma	0.0265	0.0346	CbGbCtD
Loxapine—CHRM1—Carbachol—glaucoma	0.025	0.0327	CbGbCtD
Loxapine—CHRM1—Pilocarpine—glaucoma	0.0233	0.0304	CbGbCtD
Loxapine—CHRM2—Carbachol—glaucoma	0.0231	0.0301	CbGbCtD
Loxapine—ADRA2A—Dipivefrin—glaucoma	0.0221	0.0289	CbGbCtD
Loxapine—CHRM2—Pilocarpine—glaucoma	0.0214	0.028	CbGbCtD
Loxapine—ADRA1A—Dipivefrin—glaucoma	0.0212	0.0277	CbGbCtD
Loxapine—ADRB1—Timolol—glaucoma	0.0176	0.023	CbGbCtD
Loxapine—ADRA2C—Clonidine—glaucoma	0.0174	0.0227	CbGbCtD
Loxapine—ADRA2B—Clonidine—glaucoma	0.0165	0.0216	CbGbCtD
Loxapine—ADRA1B—Clonidine—glaucoma	0.0139	0.0182	CbGbCtD
Loxapine—SLC6A2—Clonidine—glaucoma	0.0127	0.0166	CbGbCtD
Loxapine—ADRA2A—Clonidine—glaucoma	0.0115	0.015	CbGbCtD
Loxapine—ADRA1A—Clonidine—glaucoma	0.011	0.0144	CbGbCtD
Loxapine—DRD5—eyelid—glaucoma	0.0014	0.545	CbGeAlD
Loxapine—Clobazam—SLC6A1—glaucoma	0.00125	0.858	CrCbGaD
Loxapine—Tachycardia—Brimonidine—glaucoma	0.000242	0.00157	CcSEcCtD
Loxapine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000242	0.00156	CcSEcCtD
Loxapine—Dry mouth—Dorzolamide—glaucoma	0.000241	0.00156	CcSEcCtD
Loxapine—Loss of consciousness—Pilocarpine—glaucoma	0.000241	0.00156	CcSEcCtD
Loxapine—Nausea—Diclofenamide—glaucoma	0.000241	0.00156	CcSEcCtD
Loxapine—Dry mouth—Travoprost—glaucoma	0.00024	0.00156	CcSEcCtD
Loxapine—Cough—Pilocarpine—glaucoma	0.000239	0.00155	CcSEcCtD
Loxapine—Dizziness—Latanoprost—glaucoma	0.000239	0.00155	CcSEcCtD
Loxapine—Confusional state—Dorzolamide—glaucoma	0.000239	0.00154	CcSEcCtD
Loxapine—Feeling abnormal—Apraclonidine—glaucoma	0.000238	0.00154	CcSEcCtD
Loxapine—Dry mouth—Brinzolamide—glaucoma	0.000237	0.00154	CcSEcCtD
Loxapine—Vomiting—Methazolamide—glaucoma	0.000237	0.00154	CcSEcCtD
Loxapine—Oedema—Dorzolamide—glaucoma	0.000237	0.00153	CcSEcCtD
Loxapine—Hypertension—Pilocarpine—glaucoma	0.000236	0.00153	CcSEcCtD
Loxapine—Oedema—Travoprost—glaucoma	0.000236	0.00153	CcSEcCtD
Loxapine—Rash—Methazolamide—glaucoma	0.000235	0.00152	CcSEcCtD
Loxapine—Dermatitis—Methazolamide—glaucoma	0.000235	0.00152	CcSEcCtD
Loxapine—Nausea—Carbachol—glaucoma	0.000235	0.00152	CcSEcCtD
Loxapine—Headache—Methazolamide—glaucoma	0.000234	0.00151	CcSEcCtD
Loxapine—Chest pain—Pilocarpine—glaucoma	0.000233	0.00151	CcSEcCtD
Loxapine—Shock—Dorzolamide—glaucoma	0.000233	0.00151	CcSEcCtD
Loxapine—Paraesthesia—Acetazolamide—glaucoma	0.000232	0.0015	CcSEcCtD
Loxapine—Hypotension—Brimonidine—glaucoma	0.000231	0.0015	CcSEcCtD
Loxapine—Nausea—Levobunolol—glaucoma	0.000231	0.0015	CcSEcCtD
Loxapine—Nervous system disorder—Travoprost—glaucoma	0.000231	0.0015	CcSEcCtD
Loxapine—Tachycardia—Travoprost—glaucoma	0.00023	0.00149	CcSEcCtD
Loxapine—Somnolence—Acetazolamide—glaucoma	0.000229	0.00149	CcSEcCtD
Loxapine—Nervous system disorder—Brinzolamide—glaucoma	0.000228	0.00148	CcSEcCtD
Loxapine—Angiopathy—Clonidine—glaucoma	0.000228	0.00148	CcSEcCtD
Loxapine—Rash—Latanoprost—glaucoma	0.000228	0.00147	CcSEcCtD
Loxapine—Agranulocytosis—Betaxolol—glaucoma	0.000227	0.00147	CcSEcCtD
Loxapine—Dermatitis—Latanoprost—glaucoma	0.000227	0.00147	CcSEcCtD
Loxapine—Tachycardia—Brinzolamide—glaucoma	0.000227	0.00147	CcSEcCtD
Loxapine—Mediastinal disorder—Clonidine—glaucoma	0.000226	0.00147	CcSEcCtD
Loxapine—Headache—Latanoprost—glaucoma	0.000226	0.00146	CcSEcCtD
Loxapine—Confusional state—Pilocarpine—glaucoma	0.000225	0.00146	CcSEcCtD
Loxapine—Insomnia—Brimonidine—glaucoma	0.000224	0.00145	CcSEcCtD
Loxapine—Oedema—Pilocarpine—glaucoma	0.000224	0.00145	CcSEcCtD
Loxapine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000223	0.00144	CcSEcCtD
Loxapine—Fatigue—Acetazolamide—glaucoma	0.000223	0.00144	CcSEcCtD
Loxapine—Paraesthesia—Brimonidine—glaucoma	0.000222	0.00144	CcSEcCtD
Loxapine—Alopecia—Clonidine—glaucoma	0.000222	0.00144	CcSEcCtD
Loxapine—Nausea—Methazolamide—glaucoma	0.000221	0.00143	CcSEcCtD
Loxapine—Hypotension—Dorzolamide—glaucoma	0.000221	0.00143	CcSEcCtD
Loxapine—Dyspnoea—Brimonidine—glaucoma	0.000221	0.00143	CcSEcCtD
Loxapine—Somnolence—Brimonidine—glaucoma	0.00022	0.00143	CcSEcCtD
Loxapine—Hypotension—Travoprost—glaucoma	0.00022	0.00143	CcSEcCtD
Loxapine—Shock—Pilocarpine—glaucoma	0.00022	0.00142	CcSEcCtD
Loxapine—Bronchospasm—Timolol—glaucoma	0.00022	0.00142	CcSEcCtD
Loxapine—Thrombocytopenia—Pilocarpine—glaucoma	0.000219	0.00142	CcSEcCtD
Loxapine—Tachycardia—Pilocarpine—glaucoma	0.000218	0.00141	CcSEcCtD
Loxapine—Hypoaesthesia—Betaxolol—glaucoma	0.000218	0.00141	CcSEcCtD
Loxapine—Hypotension—Brinzolamide—glaucoma	0.000217	0.00141	CcSEcCtD
Loxapine—Tension—Clonidine—glaucoma	0.000215	0.00139	CcSEcCtD
Loxapine—Insomnia—Dorzolamide—glaucoma	0.000214	0.00139	CcSEcCtD
Loxapine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000214	0.00139	CcSEcCtD
Loxapine—Fatigue—Brimonidine—glaucoma	0.000214	0.00138	CcSEcCtD
Loxapine—Feeling abnormal—Acetazolamide—glaucoma	0.000213	0.00138	CcSEcCtD
Loxapine—Hypersensitivity—Apraclonidine—glaucoma	0.000213	0.00138	CcSEcCtD
Loxapine—Paraesthesia—Dorzolamide—glaucoma	0.000212	0.00138	CcSEcCtD
Loxapine—Dyspnoea—Dorzolamide—glaucoma	0.000211	0.00137	CcSEcCtD
Loxapine—Insomnia—Brinzolamide—glaucoma	0.00021	0.00136	CcSEcCtD
Loxapine—Somnolence—Dorzolamide—glaucoma	0.00021	0.00136	CcSEcCtD
Loxapine—Muscle spasms—Clonidine—glaucoma	0.00021	0.00136	CcSEcCtD
Loxapine—Dyspnoea—Travoprost—glaucoma	0.00021	0.00136	CcSEcCtD
Loxapine—Hypotension—Pilocarpine—glaucoma	0.000209	0.00135	CcSEcCtD
Loxapine—Paraesthesia—Brinzolamide—glaucoma	0.000209	0.00135	CcSEcCtD
Loxapine—Clozapine—CYP1B1—glaucoma	0.000208	0.142	CrCbGaD
Loxapine—Dyspnoea—Brinzolamide—glaucoma	0.000207	0.00134	CcSEcCtD
Loxapine—Asthenia—Apraclonidine—glaucoma	0.000207	0.00134	CcSEcCtD
Loxapine—Somnolence—Brinzolamide—glaucoma	0.000207	0.00134	CcSEcCtD
Loxapine—Vision blurred—Clonidine—glaucoma	0.000206	0.00134	CcSEcCtD
Loxapine—Tremor—Clonidine—glaucoma	0.000205	0.00133	CcSEcCtD
Loxapine—Pruritus—Apraclonidine—glaucoma	0.000204	0.00132	CcSEcCtD
Loxapine—Fatigue—Dorzolamide—glaucoma	0.000204	0.00132	CcSEcCtD
Loxapine—Gastrointestinal disorder—Travoprost—glaucoma	0.000203	0.00132	CcSEcCtD
Loxapine—Fatigue—Travoprost—glaucoma	0.000203	0.00132	CcSEcCtD
Loxapine—Insomnia—Pilocarpine—glaucoma	0.000202	0.00131	CcSEcCtD
Loxapine—Weight decreased—Timolol—glaucoma	0.000202	0.00131	CcSEcCtD
Loxapine—Constipation—Travoprost—glaucoma	0.000201	0.0013	CcSEcCtD
Loxapine—Agitation—Clonidine—glaucoma	0.000201	0.0013	CcSEcCtD
Loxapine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000201	0.0013	CcSEcCtD
Loxapine—Paraesthesia—Pilocarpine—glaucoma	0.000201	0.0013	CcSEcCtD
Loxapine—Asthenia—Bimatoprost—glaucoma	0.000201	0.0013	CcSEcCtD
Loxapine—Fatigue—Brinzolamide—glaucoma	0.000201	0.0013	CcSEcCtD
Loxapine—Dyspnoea—Pilocarpine—glaucoma	0.000199	0.00129	CcSEcCtD
Loxapine—Somnolence—Pilocarpine—glaucoma	0.000199	0.00129	CcSEcCtD
Loxapine—Angiopathy—Betaxolol—glaucoma	0.000198	0.00129	CcSEcCtD
Loxapine—Pruritus—Bimatoprost—glaucoma	0.000198	0.00128	CcSEcCtD
Loxapine—Mediastinal disorder—Betaxolol—glaucoma	0.000197	0.00128	CcSEcCtD
Loxapine—Syncope—Clonidine—glaucoma	0.000196	0.00127	CcSEcCtD
Loxapine—Feeling abnormal—Dorzolamide—glaucoma	0.000195	0.00126	CcSEcCtD
Loxapine—Feeling abnormal—Travoprost—glaucoma	0.000194	0.00126	CcSEcCtD
Loxapine—Alopecia—Betaxolol—glaucoma	0.000193	0.00125	CcSEcCtD
Loxapine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000193	0.00125	CcSEcCtD
Loxapine—Loss of consciousness—Clonidine—glaucoma	0.000192	0.00125	CcSEcCtD
Loxapine—Feeling abnormal—Brinzolamide—glaucoma	0.000192	0.00124	CcSEcCtD
Loxapine—Constipation—Pilocarpine—glaucoma	0.000191	0.00124	CcSEcCtD
Loxapine—Cough—Clonidine—glaucoma	0.000191	0.00124	CcSEcCtD
Loxapine—Dizziness—Apraclonidine—glaucoma	0.000191	0.00124	CcSEcCtD
Loxapine—Tension—Betaxolol—glaucoma	0.000187	0.00121	CcSEcCtD
Loxapine—Dysgeusia—Betaxolol—glaucoma	0.000186	0.00121	CcSEcCtD
Loxapine—Chest pain—Clonidine—glaucoma	0.000186	0.00121	CcSEcCtD
Loxapine—Agranulocytosis—Timolol—glaucoma	0.000186	0.0012	CcSEcCtD
Loxapine—Asthenia—Acetazolamide—glaucoma	0.000185	0.0012	CcSEcCtD
Loxapine—Dizziness—Bimatoprost—glaucoma	0.000185	0.0012	CcSEcCtD
Loxapine—Feeling abnormal—Pilocarpine—glaucoma	0.000184	0.00119	CcSEcCtD
Loxapine—Vomiting—Apraclonidine—glaucoma	0.000183	0.00119	CcSEcCtD
Loxapine—Muscle spasms—Betaxolol—glaucoma	0.000183	0.00119	CcSEcCtD
Loxapine—Hypersensitivity—Brimonidine—glaucoma	0.000183	0.00118	CcSEcCtD
Loxapine—Dry mouth—Clonidine—glaucoma	0.000182	0.00118	CcSEcCtD
Loxapine—Dermatitis—Apraclonidine—glaucoma	0.000182	0.00118	CcSEcCtD
Loxapine—Headache—Apraclonidine—glaucoma	0.000181	0.00117	CcSEcCtD
Loxapine—Confusional state—Clonidine—glaucoma	0.00018	0.00117	CcSEcCtD
Loxapine—Vision blurred—Betaxolol—glaucoma	0.000179	0.00116	CcSEcCtD
Loxapine—Oedema—Clonidine—glaucoma	0.000179	0.00116	CcSEcCtD
Loxapine—Tremor—Betaxolol—glaucoma	0.000178	0.00116	CcSEcCtD
Loxapine—Asthenia—Brimonidine—glaucoma	0.000178	0.00115	CcSEcCtD
Loxapine—Rash—Bimatoprost—glaucoma	0.000176	0.00114	CcSEcCtD
Loxapine—Dermatitis—Bimatoprost—glaucoma	0.000176	0.00114	CcSEcCtD
Loxapine—Shock—Clonidine—glaucoma	0.000176	0.00114	CcSEcCtD
Loxapine—Pruritus—Brimonidine—glaucoma	0.000175	0.00114	CcSEcCtD
Loxapine—Headache—Bimatoprost—glaucoma	0.000175	0.00114	CcSEcCtD
Loxapine—Nervous system disorder—Clonidine—glaucoma	0.000175	0.00113	CcSEcCtD
Loxapine—Thrombocytopenia—Clonidine—glaucoma	0.000175	0.00113	CcSEcCtD
Loxapine—Hypersensitivity—Dorzolamide—glaucoma	0.000174	0.00113	CcSEcCtD
Loxapine—Tachycardia—Clonidine—glaucoma	0.000174	0.00113	CcSEcCtD
Loxapine—Hypersensitivity—Travoprost—glaucoma	0.000174	0.00112	CcSEcCtD
Loxapine—Nausea—Apraclonidine—glaucoma	0.000171	0.00111	CcSEcCtD
Loxapine—Hypersensitivity—Brinzolamide—glaucoma	0.000171	0.00111	CcSEcCtD
Loxapine—Syncope—Betaxolol—glaucoma	0.000171	0.00111	CcSEcCtD
Loxapine—Dizziness—Acetazolamide—glaucoma	0.000171	0.00111	CcSEcCtD
Loxapine—Asthenia—Dorzolamide—glaucoma	0.00017	0.0011	CcSEcCtD
Loxapine—Asthenia—Travoprost—glaucoma	0.000169	0.00109	CcSEcCtD
Loxapine—Pruritus—Dorzolamide—glaucoma	0.000167	0.00108	CcSEcCtD
Loxapine—Loss of consciousness—Betaxolol—glaucoma	0.000167	0.00108	CcSEcCtD
Loxapine—Asthenia—Brinzolamide—glaucoma	0.000167	0.00108	CcSEcCtD
Loxapine—Hypotension—Clonidine—glaucoma	0.000167	0.00108	CcSEcCtD
Loxapine—Pruritus—Travoprost—glaucoma	0.000167	0.00108	CcSEcCtD
Loxapine—Cough—Betaxolol—glaucoma	0.000166	0.00108	CcSEcCtD
Loxapine—Nausea—Bimatoprost—glaucoma	0.000166	0.00108	CcSEcCtD
Loxapine—Hypersensitivity—Pilocarpine—glaucoma	0.000165	0.00107	CcSEcCtD
Loxapine—Pruritus—Brinzolamide—glaucoma	0.000165	0.00107	CcSEcCtD
Loxapine—Vomiting—Acetazolamide—glaucoma	0.000164	0.00106	CcSEcCtD
Loxapine—Dizziness—Brimonidine—glaucoma	0.000164	0.00106	CcSEcCtD
Loxapine—Angiopathy—Timolol—glaucoma	0.000162	0.00105	CcSEcCtD
Loxapine—Chest pain—Betaxolol—glaucoma	0.000162	0.00105	CcSEcCtD
Loxapine—Headache—Acetazolamide—glaucoma	0.000162	0.00105	CcSEcCtD
Loxapine—Insomnia—Clonidine—glaucoma	0.000161	0.00105	CcSEcCtD
Loxapine—Mediastinal disorder—Timolol—glaucoma	0.000161	0.00104	CcSEcCtD
Loxapine—Asthenia—Pilocarpine—glaucoma	0.00016	0.00104	CcSEcCtD
Loxapine—Paraesthesia—Clonidine—glaucoma	0.00016	0.00104	CcSEcCtD
Loxapine—Dyspnoea—Clonidine—glaucoma	0.000159	0.00103	CcSEcCtD
Loxapine—Somnolence—Clonidine—glaucoma	0.000159	0.00103	CcSEcCtD
Loxapine—Dry mouth—Betaxolol—glaucoma	0.000159	0.00103	CcSEcCtD
Loxapine—Pruritus—Pilocarpine—glaucoma	0.000158	0.00102	CcSEcCtD
Loxapine—Alopecia—Timolol—glaucoma	0.000158	0.00102	CcSEcCtD
Loxapine—Confusional state—Betaxolol—glaucoma	0.000157	0.00101	CcSEcCtD
Loxapine—Dizziness—Dorzolamide—glaucoma	0.000156	0.00101	CcSEcCtD
Loxapine—Rash—Brimonidine—glaucoma	0.000156	0.00101	CcSEcCtD
Loxapine—Dermatitis—Brimonidine—glaucoma	0.000156	0.00101	CcSEcCtD
Loxapine—Dizziness—Travoprost—glaucoma	0.000156	0.00101	CcSEcCtD
Loxapine—Oedema—Betaxolol—glaucoma	0.000155	0.00101	CcSEcCtD
Loxapine—Headache—Brimonidine—glaucoma	0.000155	0.00101	CcSEcCtD
Loxapine—Gastrointestinal disorder—Clonidine—glaucoma	0.000154	0.000998	CcSEcCtD
Loxapine—Fatigue—Clonidine—glaucoma	0.000154	0.000997	CcSEcCtD
Loxapine—Dizziness—Brinzolamide—glaucoma	0.000154	0.000996	CcSEcCtD
Loxapine—Nausea—Acetazolamide—glaucoma	0.000153	0.000993	CcSEcCtD
Loxapine—Shock—Betaxolol—glaucoma	0.000153	0.00099	CcSEcCtD
Loxapine—Tension—Timolol—glaucoma	0.000153	0.000989	CcSEcCtD
Loxapine—Constipation—Clonidine—glaucoma	0.000153	0.000989	CcSEcCtD
Loxapine—Nervous system disorder—Betaxolol—glaucoma	0.000152	0.000987	CcSEcCtD
Loxapine—Dysgeusia—Timolol—glaucoma	0.000152	0.000987	CcSEcCtD
Loxapine—Thrombocytopenia—Betaxolol—glaucoma	0.000152	0.000986	CcSEcCtD
Loxapine—HTR7—endothelium—glaucoma	0.000152	0.0591	CbGeAlD
Loxapine—Tachycardia—Betaxolol—glaucoma	0.000152	0.000982	CcSEcCtD
Loxapine—Vomiting—Dorzolamide—glaucoma	0.00015	0.000974	CcSEcCtD
Loxapine—Rash—Dorzolamide—glaucoma	0.000149	0.000966	CcSEcCtD
Loxapine—Dermatitis—Dorzolamide—glaucoma	0.000149	0.000965	CcSEcCtD
Loxapine—Rash—Travoprost—glaucoma	0.000149	0.000962	CcSEcCtD
Loxapine—Dermatitis—Travoprost—glaucoma	0.000148	0.000961	CcSEcCtD
Loxapine—Headache—Dorzolamide—glaucoma	0.000148	0.00096	CcSEcCtD
Loxapine—Vomiting—Brinzolamide—glaucoma	0.000148	0.000958	CcSEcCtD
Loxapine—Dizziness—Pilocarpine—glaucoma	0.000148	0.000957	CcSEcCtD
Loxapine—Headache—Travoprost—glaucoma	0.000148	0.000956	CcSEcCtD
Loxapine—Nausea—Brimonidine—glaucoma	0.000147	0.000953	CcSEcCtD
Loxapine—Feeling abnormal—Clonidine—glaucoma	0.000147	0.000953	CcSEcCtD
Loxapine—Rash—Brinzolamide—glaucoma	0.000147	0.00095	CcSEcCtD
Loxapine—Vision blurred—Timolol—glaucoma	0.000147	0.00095	CcSEcCtD
Loxapine—Dermatitis—Brinzolamide—glaucoma	0.000147	0.000949	CcSEcCtD
Loxapine—Headache—Brinzolamide—glaucoma	0.000146	0.000944	CcSEcCtD
Loxapine—Hypotension—Betaxolol—glaucoma	0.000145	0.000941	CcSEcCtD
Loxapine—Vomiting—Pilocarpine—glaucoma	0.000142	0.000921	CcSEcCtD
Loxapine—Rash—Pilocarpine—glaucoma	0.000141	0.000913	CcSEcCtD
Loxapine—Dermatitis—Pilocarpine—glaucoma	0.000141	0.000912	CcSEcCtD
Loxapine—Insomnia—Betaxolol—glaucoma	0.000141	0.00091	CcSEcCtD
Loxapine—Nausea—Dorzolamide—glaucoma	0.000141	0.00091	CcSEcCtD
Loxapine—CHRM5—eye—glaucoma	0.00014	0.0545	CbGeAlD
Loxapine—Headache—Pilocarpine—glaucoma	0.00014	0.000907	CcSEcCtD
Loxapine—Nausea—Travoprost—glaucoma	0.00014	0.000906	CcSEcCtD
Loxapine—Paraesthesia—Betaxolol—glaucoma	0.00014	0.000904	CcSEcCtD
Loxapine—Syncope—Timolol—glaucoma	0.00014	0.000904	CcSEcCtD
Loxapine—Dyspnoea—Betaxolol—glaucoma	0.000139	0.000897	CcSEcCtD
Loxapine—Nausea—Brinzolamide—glaucoma	0.000138	0.000895	CcSEcCtD
Loxapine—Loss of consciousness—Timolol—glaucoma	0.000137	0.000886	CcSEcCtD
Loxapine—Cough—Timolol—glaucoma	0.000136	0.000879	CcSEcCtD
Loxapine—Hypertension—Timolol—glaucoma	0.000134	0.00087	CcSEcCtD
Loxapine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000134	0.000869	CcSEcCtD
Loxapine—Fatigue—Betaxolol—glaucoma	0.000134	0.000868	CcSEcCtD
Loxapine—Constipation—Betaxolol—glaucoma	0.000133	0.000861	CcSEcCtD
Loxapine—Nausea—Pilocarpine—glaucoma	0.000133	0.00086	CcSEcCtD
Loxapine—Chest pain—Timolol—glaucoma	0.000132	0.000858	CcSEcCtD
Loxapine—Hypersensitivity—Clonidine—glaucoma	0.000132	0.000852	CcSEcCtD
Loxapine—Dry mouth—Timolol—glaucoma	0.00013	0.000839	CcSEcCtD
Loxapine—Asthenia—Clonidine—glaucoma	0.000128	0.00083	CcSEcCtD
Loxapine—Feeling abnormal—Betaxolol—glaucoma	0.000128	0.000829	CcSEcCtD
Loxapine—Confusional state—Timolol—glaucoma	0.000128	0.000829	CcSEcCtD
Loxapine—Oedema—Timolol—glaucoma	0.000127	0.000822	CcSEcCtD
Loxapine—Pruritus—Clonidine—glaucoma	0.000126	0.000818	CcSEcCtD
Loxapine—Shock—Timolol—glaucoma	0.000125	0.000809	CcSEcCtD
Loxapine—Nervous system disorder—Timolol—glaucoma	0.000125	0.000806	CcSEcCtD
Loxapine—Hypotension—Timolol—glaucoma	0.000119	0.000768	CcSEcCtD
Loxapine—Dizziness—Clonidine—glaucoma	0.000118	0.000765	CcSEcCtD
Loxapine—Insomnia—Timolol—glaucoma	0.000115	0.000744	CcSEcCtD
Loxapine—Hypersensitivity—Betaxolol—glaucoma	0.000115	0.000742	CcSEcCtD
Loxapine—Paraesthesia—Timolol—glaucoma	0.000114	0.000738	CcSEcCtD
Loxapine—Vomiting—Clonidine—glaucoma	0.000114	0.000735	CcSEcCtD
Loxapine—Dyspnoea—Timolol—glaucoma	0.000113	0.000733	CcSEcCtD
Loxapine—Somnolence—Timolol—glaucoma	0.000113	0.000731	CcSEcCtD
Loxapine—Rash—Clonidine—glaucoma	0.000113	0.000729	CcSEcCtD
Loxapine—Dermatitis—Clonidine—glaucoma	0.000112	0.000728	CcSEcCtD
Loxapine—Headache—Clonidine—glaucoma	0.000112	0.000724	CcSEcCtD
Loxapine—Asthenia—Betaxolol—glaucoma	0.000112	0.000722	CcSEcCtD
Loxapine—Pruritus—Betaxolol—glaucoma	0.00011	0.000712	CcSEcCtD
Loxapine—Gastrointestinal disorder—Timolol—glaucoma	0.00011	0.00071	CcSEcCtD
Loxapine—Fatigue—Timolol—glaucoma	0.000109	0.000709	CcSEcCtD
Loxapine—Nausea—Clonidine—glaucoma	0.000106	0.000687	CcSEcCtD
Loxapine—Feeling abnormal—Timolol—glaucoma	0.000105	0.000678	CcSEcCtD
Loxapine—Dizziness—Betaxolol—glaucoma	0.000103	0.000666	CcSEcCtD
Loxapine—Vomiting—Betaxolol—glaucoma	9.88e-05	0.00064	CcSEcCtD
Loxapine—Rash—Betaxolol—glaucoma	9.8e-05	0.000635	CcSEcCtD
Loxapine—Dermatitis—Betaxolol—glaucoma	9.79e-05	0.000634	CcSEcCtD
Loxapine—Headache—Betaxolol—glaucoma	9.74e-05	0.000631	CcSEcCtD
Loxapine—HTR2A—endothelium—glaucoma	9.49e-05	0.0368	CbGeAlD
Loxapine—HTR1D—eye—glaucoma	9.37e-05	0.0364	CbGeAlD
Loxapine—Hypersensitivity—Timolol—glaucoma	9.35e-05	0.000606	CcSEcCtD
Loxapine—Nausea—Betaxolol—glaucoma	9.23e-05	0.000598	CcSEcCtD
Loxapine—Asthenia—Timolol—glaucoma	9.11e-05	0.00059	CcSEcCtD
Loxapine—HTR1D—connective tissue—glaucoma	9.03e-05	0.0351	CbGeAlD
Loxapine—Pruritus—Timolol—glaucoma	8.98e-05	0.000582	CcSEcCtD
Loxapine—ADRB1—connective tissue—glaucoma	8.78e-05	0.0341	CbGeAlD
Loxapine—Dizziness—Timolol—glaucoma	8.4e-05	0.000544	CcSEcCtD
Loxapine—Vomiting—Timolol—glaucoma	8.07e-05	0.000523	CcSEcCtD
Loxapine—Rash—Timolol—glaucoma	8.01e-05	0.000518	CcSEcCtD
Loxapine—Dermatitis—Timolol—glaucoma	8e-05	0.000518	CcSEcCtD
Loxapine—Headache—Timolol—glaucoma	7.95e-05	0.000515	CcSEcCtD
Loxapine—Nausea—Timolol—glaucoma	7.54e-05	0.000488	CcSEcCtD
Loxapine—HTR7—connective tissue—glaucoma	7.19e-05	0.0279	CbGeAlD
Loxapine—DRD2—eye—glaucoma	7.06e-05	0.0274	CbGeAlD
Loxapine—DRD2—retina—glaucoma	7e-05	0.0272	CbGeAlD
Loxapine—HRH1—eye—glaucoma	5.57e-05	0.0216	CbGeAlD
Loxapine—HRH1—connective tissue—glaucoma	5.37e-05	0.0208	CbGeAlD
Loxapine—ADRA2A—connective tissue—glaucoma	5.28e-05	0.0205	CbGeAlD
Loxapine—HTR2A—eye—glaucoma	4.66e-05	0.0181	CbGeAlD
Loxapine—HTR2A—retina—glaucoma	4.61e-05	0.0179	CbGeAlD
Loxapine—HTR2A—connective tissue—glaucoma	4.49e-05	0.0174	CbGeAlD
Loxapine—DRD1—Signaling Pathways—CAV1—glaucoma	6.04e-06	7.95e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—FN1—glaucoma	6.03e-06	7.94e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NGFR—glaucoma	6.03e-06	7.93e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—APOE—glaucoma	6.01e-06	7.91e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—CAV1—glaucoma	6.01e-06	7.91e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—CDKN1B—glaucoma	5.99e-06	7.88e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—GSTM1—glaucoma	5.98e-06	7.88e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—BAD—glaucoma	5.96e-06	7.84e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CAV1—glaucoma	5.96e-06	7.84e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—CDKN1B—glaucoma	5.95e-06	7.83e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NGF—glaucoma	5.92e-06	7.79e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CDKN2B—glaucoma	5.89e-06	7.76e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NGF—glaucoma	5.89e-06	7.75e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—C3—glaucoma	5.88e-06	7.74e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—C3—glaucoma	5.83e-06	7.67e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CDKN2B—glaucoma	5.8e-06	7.63e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CDKN2B—glaucoma	5.79e-06	7.62e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	5.77e-06	7.59e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—MTHFR—glaucoma	5.76e-06	7.59e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	5.75e-06	7.57e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—FN1—glaucoma	5.74e-06	7.56e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NGF—glaucoma	5.73e-06	7.54e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	5.73e-06	7.54e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	5.69e-06	7.49e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	5.68e-06	7.47e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—BAD—glaucoma	5.68e-06	7.47e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—FN1—glaucoma	5.67e-06	7.46e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EDN1—glaucoma	5.66e-06	7.44e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NGF—glaucoma	5.64e-06	7.42e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—C3—glaucoma	5.63e-06	7.41e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—BAD—glaucoma	5.6e-06	7.37e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—C3—glaucoma	5.6e-06	7.37e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—VEGFA—glaucoma	5.59e-06	7.36e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EDN1—glaucoma	5.56e-06	7.32e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EDN1—glaucoma	5.55e-06	7.31e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—MMP9—glaucoma	5.55e-06	7.3e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EDN1—glaucoma	5.53e-06	7.29e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EDN1—glaucoma	5.52e-06	7.26e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—MMP9—glaucoma	5.51e-06	7.25e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—APOE—glaucoma	5.48e-06	7.21e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EDN1—glaucoma	5.46e-06	7.19e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EDN1—glaucoma	5.45e-06	7.17e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—C3—glaucoma	5.44e-06	7.17e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—APOE—glaucoma	5.43e-06	7.14e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CAV1—glaucoma	5.43e-06	7.14e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CAV1—glaucoma	5.38e-06	7.08e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—APOE—glaucoma	5.37e-06	7.06e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—C3—glaucoma	5.36e-06	7.05e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—CAV1—glaucoma	5.32e-06	7e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—NOS3—glaucoma	5.3e-06	6.98e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—NOS3—glaucoma	5.3e-06	6.97e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—MTHFR—glaucoma	5.29e-06	6.96e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	5.28e-06	6.94e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—NOS3—glaucoma	5.26e-06	6.93e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—APOE—glaucoma	5.24e-06	6.9e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—APOE—glaucoma	5.21e-06	6.86e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NGF—glaucoma	5.2e-06	6.84e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CAV1—glaucoma	5.19e-06	6.83e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—FN1—glaucoma	5.16e-06	6.8e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CAV1—glaucoma	5.16e-06	6.8e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—NOS3—glaucoma	5.15e-06	6.78e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—FN1—glaucoma	5.12e-06	6.74e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NGF—glaucoma	5.11e-06	6.73e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—BAD—glaucoma	5.1e-06	6.72e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NGF—glaucoma	5.1e-06	6.72e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NGF—glaucoma	5.09e-06	6.7e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NGF—glaucoma	5.07e-06	6.67e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—NOS3—glaucoma	5.07e-06	6.67e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—APOE—glaucoma	5.07e-06	6.67e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EDN1—glaucoma	5.06e-06	6.66e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—BAD—glaucoma	5.06e-06	6.66e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CAV1—glaucoma	5.02e-06	6.61e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NGF—glaucoma	5.02e-06	6.61e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NGF—glaucoma	5.01e-06	6.59e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—NOS3—glaucoma	5e-06	6.58e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—APOE—glaucoma	4.99e-06	6.57e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—VEGFA—glaucoma	4.98e-06	6.56e-05	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—TP53—glaucoma	4.95e-06	6.52e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—VEGFA—glaucoma	4.95e-06	6.51e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CAV1—glaucoma	4.94e-06	6.51e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—C3—glaucoma	4.94e-06	6.5e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—FN1—glaucoma	4.94e-06	6.5e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—APOE—glaucoma	4.92e-06	6.48e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—FN1—glaucoma	4.91e-06	6.47e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—BAD—glaucoma	4.88e-06	6.43e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—CAV1—glaucoma	4.88e-06	6.42e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—C3—glaucoma	4.86e-06	6.4e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—BAD—glaucoma	4.86e-06	6.39e-05	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—TP53—glaucoma	4.85e-06	6.39e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—C3—glaucoma	4.85e-06	6.39e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—C3—glaucoma	4.84e-06	6.36e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—C3—glaucoma	4.82e-06	6.34e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NOS3—glaucoma	4.79e-06	6.3e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—FN1—glaucoma	4.78e-06	6.29e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—C3—glaucoma	4.77e-06	6.28e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—C3—glaucoma	4.76e-06	6.27e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—BAD—glaucoma	4.72e-06	6.22e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—FN1—glaucoma	4.7e-06	6.19e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NGF—glaucoma	4.65e-06	6.12e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—BAD—glaucoma	4.65e-06	6.12e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—APOE—glaucoma	4.6e-06	6.05e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—CDKN1B—glaucoma	4.59e-06	6.05e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CDKN1B—glaucoma	4.59e-06	6.04e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NOS3—glaucoma	4.56e-06	6.01e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CDKN1B—glaucoma	4.56e-06	6e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CAV1—glaucoma	4.56e-06	6e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—NOS3—glaucoma	4.54e-06	5.98e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—APOE—glaucoma	4.53e-06	5.96e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—APOE—glaucoma	4.52e-06	5.94e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NOS3—glaucoma	4.5e-06	5.93e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—APOE—glaucoma	4.5e-06	5.93e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—APOE—glaucoma	4.49e-06	5.91e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CAV1—glaucoma	4.48e-06	5.9e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CAV1—glaucoma	4.47e-06	5.89e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CDKN1B—glaucoma	4.46e-06	5.87e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CAV1—glaucoma	4.46e-06	5.87e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CAV1—glaucoma	4.45e-06	5.85e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—APOE—glaucoma	4.44e-06	5.85e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—APOE—glaucoma	4.43e-06	5.83e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—C3—glaucoma	4.42e-06	5.82e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CAV1—glaucoma	4.4e-06	5.8e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CDKN1B—glaucoma	4.39e-06	5.78e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CAV1—glaucoma	4.39e-06	5.78e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—FN1—glaucoma	4.34e-06	5.71e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	4.33e-06	5.7e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—BAD—glaucoma	4.29e-06	5.64e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—FN1—glaucoma	4.27e-06	5.62e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—FN1—glaucoma	4.26e-06	5.61e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MMP9—glaucoma	4.25e-06	5.6e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MMP9—glaucoma	4.25e-06	5.59e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—FN1—glaucoma	4.24e-06	5.59e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—FN1—glaucoma	4.23e-06	5.57e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—TP53—glaucoma	4.22e-06	5.56e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MMP9—glaucoma	4.22e-06	5.56e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—BAD—glaucoma	4.22e-06	5.55e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—BAD—glaucoma	4.21e-06	5.54e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—BAD—glaucoma	4.19e-06	5.52e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FN1—glaucoma	4.19e-06	5.52e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—BAD—glaucoma	4.18e-06	5.5e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FN1—glaucoma	4.18e-06	5.5e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PTGS2—glaucoma	4.15e-06	5.47e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	4.15e-06	5.46e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—BAD—glaucoma	4.14e-06	5.45e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MMP9—glaucoma	4.13e-06	5.44e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—BAD—glaucoma	4.13e-06	5.44e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—APOE—glaucoma	4.12e-06	5.42e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NOS3—glaucoma	4.1e-06	5.4e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CAV1—glaucoma	4.08e-06	5.37e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MMP9—glaucoma	4.07e-06	5.35e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NOS3—glaucoma	4.07e-06	5.35e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—NOS3—glaucoma	4.02e-06	5.29e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MMP9—glaucoma	4.01e-06	5.28e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CDKN1B—glaucoma	3.95e-06	5.2e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOS3—glaucoma	3.92e-06	5.17e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOS3—glaucoma	3.9e-06	5.14e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CDKN1B—glaucoma	3.9e-06	5.13e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FN1—glaucoma	3.88e-06	5.11e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—glaucoma	3.84e-06	5.06e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—BAD—glaucoma	3.84e-06	5.05e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—VEGFA—glaucoma	3.82e-06	5.03e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—VEGFA—glaucoma	3.82e-06	5.02e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—glaucoma	3.8e-06	5e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—VEGFA—glaucoma	3.79e-06	4.99e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—glaucoma	3.76e-06	4.95e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—glaucoma	3.74e-06	4.92e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—glaucoma	3.74e-06	4.92e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—VEGFA—glaucoma	3.71e-06	4.89e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—glaucoma	3.69e-06	4.86e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTGS2—glaucoma	3.68e-06	4.84e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—glaucoma	3.66e-06	4.82e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—VEGFA—glaucoma	3.65e-06	4.81e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—glaucoma	3.61e-06	4.76e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—VEGFA—glaucoma	3.6e-06	4.74e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CDKN1B—glaucoma	3.55e-06	4.68e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	3.52e-06	4.64e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—glaucoma	3.45e-06	4.54e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—glaucoma	3.45e-06	4.54e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CDKN1B—glaucoma	3.4e-06	4.48e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—glaucoma	3.39e-06	4.46e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—glaucoma	3.38e-06	4.45e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CDKN1B—glaucoma	3.38e-06	4.45e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—glaucoma	3.37e-06	4.44e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—glaucoma	3.37e-06	4.44e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—glaucoma	3.36e-06	4.42e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—glaucoma	3.33e-06	4.38e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—glaucoma	3.32e-06	4.37e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—glaucoma	3.29e-06	4.33e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	3.29e-06	4.33e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—glaucoma	3.29e-06	4.33e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—glaucoma	3.26e-06	4.29e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—glaucoma	3.24e-06	4.27e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	3.24e-06	4.26e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—glaucoma	3.15e-06	4.14e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—glaucoma	3.13e-06	4.12e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—glaucoma	3.08e-06	4.06e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—glaucoma	3.05e-06	4.01e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—glaucoma	3e-06	3.95e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CDKN1B—glaucoma	2.98e-06	3.93e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—glaucoma	2.96e-06	3.89e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CDKN1B—glaucoma	2.94e-06	3.87e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CDKN1B—glaucoma	2.93e-06	3.86e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—glaucoma	2.93e-06	3.86e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	2.92e-06	3.85e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	2.91e-06	3.83e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—glaucoma	2.89e-06	3.8e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	2.88e-06	3.8e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—glaucoma	2.88e-06	3.79e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.88e-06	3.79e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—glaucoma	2.86e-06	3.77e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—glaucoma	2.83e-06	3.72e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—glaucoma	2.81e-06	3.7e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—glaucoma	2.8e-06	3.69e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—glaucoma	2.76e-06	3.64e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—glaucoma	2.76e-06	3.63e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—glaucoma	2.74e-06	3.6e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—glaucoma	2.72e-06	3.58e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—glaucoma	2.72e-06	3.58e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—glaucoma	2.71e-06	3.57e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—glaucoma	2.71e-06	3.56e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—glaucoma	2.7e-06	3.55e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—glaucoma	2.69e-06	3.54e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2.67e-06	3.52e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—glaucoma	2.67e-06	3.52e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—glaucoma	2.66e-06	3.51e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—glaucoma	2.61e-06	3.43e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—glaucoma	2.48e-06	3.27e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—glaucoma	2.48e-06	3.27e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—glaucoma	2.47e-06	3.26e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—glaucoma	2.45e-06	3.23e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—glaucoma	2.44e-06	3.22e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—glaucoma	2.44e-06	3.21e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—glaucoma	2.43e-06	3.2e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—glaucoma	2.42e-06	3.19e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.4e-06	3.16e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	2.39e-06	3.15e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—glaucoma	2.23e-06	2.94e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	2.22e-06	2.93e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—glaucoma	2.21e-06	2.91e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—glaucoma	2.14e-06	2.81e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—glaucoma	2.13e-06	2.8e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—glaucoma	2.07e-06	2.72e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—glaucoma	2.03e-06	2.68e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—glaucoma	1.88e-06	2.47e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—glaucoma	1.85e-06	2.43e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—glaucoma	1.84e-06	2.42e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—glaucoma	1.84e-06	2.42e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—glaucoma	1.83e-06	2.41e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—glaucoma	1.81e-06	2.39e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—glaucoma	1.81e-06	2.38e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—glaucoma	1.68e-06	2.21e-05	CbGpPWpGaD
